Modulation of p53-induced cell cycle progression, DNA repair and apoptosis by HCV gene expression.
HCV 基因表达调节 p53 诱导的细胞周期进程、DNA 修复和细胞凋亡。
基本信息
- 批准号:08457163
- 负责人:
- 金额:$ 2.56万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1996
- 资助国家:日本
- 起止时间:1996 至 1997
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The role of p53 and HCV gene expresssion on cell cycle progression, apoptosis, and DNA reapir was investigated. Anticancer drugs such as etoposide and mitomycin C induced apoptosis in human PLC/PRF/5 hepatoma cells. Nuclear accumulation of p53 was observed preceeding the apoptosis. To investigate the role of p53, we introduced p53 gene into a retroviral expression vecotr pZIP,and the retrovirus carryiing p53 gene was produced. The growth of hepatoma cells in vivo and in vivo was inhihibed by the transfer of wild-type p53 gene.An antiangiogenic compound TNP470, a derivative of Fumagillin, induced apoptosis in both hepatoma cells and vascular endothelial cells and suppressed the in vivo growth of hepatoma cells. p53 acted additively with this anti-angiogenic compound. Apoptosis of the hepatoma cells appeared to be regulated by ras-PI-3-kinase pathway and NF-kB.Both TNP470 and p53 was suggested to be playing important role in modulating these pathways and inducining apoptosis.In order to analyze the effects of HCV gene expression, the viral gene fragments were introduced into the retroviral expression vector. The analysis on the effects of expression on these genes on ras-PI-3kinase and NF-kB is known in progress.
研究了p53和HCV基因表达在细胞周期进程、细胞凋亡和DNA修复中的作用。抗癌药物足叶乙甙和丝裂霉素C诱导人肝癌PLC/PRF/5细胞凋亡。p53蛋白在细胞凋亡前有核聚集。为了研究p53基因在逆转录病毒中的作用,我们将p53基因导入逆转录病毒表达载体pZIP中,制备了携带p53基因的逆转录病毒。野生型p53基因的导入抑制了肝癌细胞在体内和体内的生长,抗血管生成化合物烟曲霉素(Fumagillin)衍生物TNP 470诱导肝癌细胞和血管内皮细胞凋亡,抑制肝癌细胞在体内的生长。p53与这种抗血管生成化合物起相加作用。肝癌细胞的凋亡受ras-PI-3-kinase通路和NF-κ B的调控,提示TNP 470和p53在调控这些通路和诱导凋亡中起重要作用。这些基因的表达对ras-PI-3激酶和NF-κ B的影响的分析正在进行中。
项目成果
期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
T.Nakayama.: "k252a inhibits the phosphorylation of PRb without chcmging the levels of G1 cyclins and cdk2 proteins in human hepatomd cells." Biochem.Biophys.Res.Commun. 224. 180-183 (1996)
T.Nakayama.:“k252a 抑制 PRb 的磷酸化,而不改变人肝细胞中 G1 细胞周期蛋白和 cdk2 蛋白的水平。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y.Kaneko: "Cationic liposomes enhance retrovirua-mediated multinucleated cel formation and retroviral transduction." Cancer Lett.105. 39-44 (1996)
Y.Kaneko:“阳离子脂质体增强逆转录病毒介导的多核细胞形成和逆转录病毒转导。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y.Kaneko: "Structural characteristics of cationic lipasomes with potent enhancing effect on retroviral transduction into human hepatomc) cells." Cancer Lett. 107. 211-215 (1996)
Y.Kaneko:“阳离子脂质体的结构特征,对逆转录病毒转导至人肝细胞具有有效增强作用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
T.Nakayama: "K252a inhibits the phosphorylation of pRb without changing the levels of G1 cyclins and cdk 2 proteins in human hepatomc) cells." Biochem.Biophup.Res.Commun. 224. 180-183 (1996)
T.Nakayama:“K252a 抑制 pRb 的磷酸化,而不改变人肝细胞中 G1 细胞周期蛋白和 cdk 2 蛋白的水平。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y.Kaneko: "Structural Characteristics of cationic liposomes with potent enhancing effect on retroviral transduction into hunan heparomd cells" Cancer Lett. 107. 211-215 (1996)
Y.Kaneko:“对逆转录病毒转导至湖南肝细胞具有有效增强作用的阳离子脂质体的结构特征”Cancer Lett。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KANEKO Yoshiyasu其他文献
KANEKO Yoshiyasu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KANEKO Yoshiyasu', 18)}}的其他基金
Alterations of opoptosis and cell cycle resulation induced by heptatitis Cvirus
丙型肝炎病毒诱导的细胞凋亡和细胞周期改变的改变
- 批准号:
06454257 - 财政年份:1994
- 资助金额:
$ 2.56万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Effects of hepatitis virus gene expression on the action of tumor promoters
肝炎病毒基因表达对肿瘤促进剂作用的影响
- 批准号:
04670410 - 财政年份:1992
- 资助金额:
$ 2.56万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
signal Transduction pathways in regenerating liver and the role of HBV X gene
肝脏再生信号转导通路及HBV X基因的作用
- 批准号:
02670294 - 财政年份:1990
- 资助金额:
$ 2.56万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Sequential expression of c-oncs in regenerating liver.
再生肝脏中 c-oncs 的顺序表达。
- 批准号:
63570316 - 财政年份:1988
- 资助金额:
$ 2.56万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Re-engineered Mitochondrially Targeted p53 Gene Therapy in Liver Cancer
重新设计的线粒体靶向 p53 基因疗法治疗肝癌
- 批准号:
10317129 - 财政年份:2021
- 资助金额:
$ 2.56万 - 项目类别:
Exploration of metabolic factors to inhibit tumor-specific p53 gene therapy in pancreatic cancer
代谢因素抑制胰腺癌肿瘤特异性p53基因治疗的探索
- 批准号:
21K07219 - 财政年份:2021
- 资助金额:
$ 2.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mapping the indirect p53 gene regulatory network
绘制间接 p53 基因调控网络
- 批准号:
338723864 - 财政年份:2017
- 资助金额:
$ 2.56万 - 项目类别:
Research Grants
Preclinical study of tumor-specific p53 gene therapy against refractory pancreatic cancer
肿瘤特异性p53基因治疗难治性胰腺癌的临床前研究
- 批准号:
16K10596 - 财政年份:2016
- 资助金额:
$ 2.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of cleft palate mechanism using p53 gene-deficient consomic mice
p53基因缺陷小鼠的腭裂机制分析
- 批准号:
16H05539 - 财政年份:2016
- 资助金额:
$ 2.56万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
the role of p53 gene in maintenance of circadian rhythm
p53基因在维持昼夜节律中的作用
- 批准号:
23790838 - 财政年份:2011
- 资助金额:
$ 2.56万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
An analysis of the mechanisms of loss of immune system in T cell induced by p53 gene instability after irradiation at a young age
幼年照射后p53基因不稳定导致T细胞免疫功能丧失的机制分析
- 批准号:
23510070 - 财政年份:2011
- 资助金额:
$ 2.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Risk for in vivo mutagenesis of the P53 gene by nucleoside analog antiviral drug
核苷类似物抗病毒药物体内 P53 基因突变的风险
- 批准号:
8150962 - 财政年份:2010
- 资助金额:
$ 2.56万 - 项目类别:
Risk for in vivo mutagenesis of the P53 gene by nucleoside analog antiviral drug
核苷类似物抗病毒药物体内 P53 基因突变的风险
- 批准号:
7991946 - 财政年份:2010
- 资助金额:
$ 2.56万 - 项目类别:
Function of the alternatively spliced p53 gene
选择性剪接 p53 基因的功能
- 批准号:
3475-2009 - 财政年份:2009
- 资助金额:
$ 2.56万 - 项目类别:
Discovery Grants Program - Individual